NCT00055549View on ClinicalTrials.gov

Dextromethorphan to Treat Patients With Voice Spasms

PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 4, 2003

Primary Completion Date

November 13, 2009

Study Completion Date

November 13, 2009

Conditions
Voice Disorders
Interventions
DRUG

Dextromethorphan

DRUG

Lorazepam

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00055549 - Dextromethorphan to Treat Patients With Voice Spasms | Biotech Hunter | Biotech Hunter